A Novel Class of Human ADAM8 Inhibitory Antibodies for Treatment of Triple-Negative Breast Cancer.
- Resource Type
- Article
- Source
- Pharmaceutics; Apr2024, Vol. 16 Issue 4, p536, 19p
- Subject
TRIPLE-negative breast cancer MONOCLONAL antibodies PROTEIN conformation THERAPEUTICS FLOW cytometry IMMUNOGLOBULINS - Language
- ISSN
- 19994923